Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00362700
Status:
TERMINATED
Last Update Posted:
2017-02-01
First Post:
2006-08-08
Brief Title:
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
Sponsor:
Bukwang Pharmaceutical
Organization:
Bukwang Pharmaceutical
Organization Data
Organization:
Bukwang Pharmaceutical
Class:
INDUSTRY
Study ID:
L-FMAU-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bukwang Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None